A Pilot Study to Assess Feasibility of Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients Awaiting Liver Transplantation
The purpose of this study is to see if the addition of radiation therapy to the liver is a safe and practical treatment for patients with liver cancer and cirrhosis who are awaiting liver transplantation.
Hepatocellular Carcinoma (HCC) and liver cirrhosis
18 years and older; diagnosis of Hepatocellular Carcinoma and recommended for liver transplant; diagnosis of liver cirrhosis; no prior radiotherapy to the abdomen.
18 - 100
Healthy Volunteers Needed
Duration of Participation
The portion of the study treatment (radiation therapy) lasts only for 2 weeks. After that you are followed until disease progression, transplant, or two years after radiation therapy, whichever comes first..
Sr. Research Assistant
OHSU Radiation Medicine